Nittobo America

What Nittobo America does

Nittobo America Inc. (NTB-A) is a primary manufacturer of bulk polyclonal antisera and complementing raw materials — including calibrators, controls, antigens, and monoclonal antibodies — for the in-vitro diagnostic (IVD) immunodiagnostic assay industry. The company serves IVD diagnostic kit manufacturers globally, supplying the biological inputs that go into turbidimetric immunoassays (TIA) and other diagnostic applications. NTB-A operates through three consolidated brands: IIC (founded 1982, Murrieta, California), MBC (founded 1987, Boone, Iowa), and Capricorn (founded 1994, acquired June 2019 and merged effective January 2020, Portland, Maine). Together the three facilities span 172 acres of USDA-licensed farmland and are each ISO 9001 certified and registered as USDA Technical Plants approved for EU export under EC 1060/2009 and 142/2011.

The company's core technology centers on polyclonal antiserum production in goats (and sheep), using automated plasmapheresis to enable high-volume collection at competitive cost. Products are offered in multiple processing forms — raw serum, gamma fraction, IgG fraction, and immunoaffinity-purified antibody — each tailored for specific downstream uses such as latex binding in turbidimetric assays or enzyme conjugation. The catalog spans antisera to human immunoglobulins (IgA, IgE, IgG, IgM, kappa/lambda light chains), apolipoproteins (Apo AI, Apo AII, Apo B, Apo C-II/III, Apo E, Lp(a)), cardiac markers (CKMM, myoglobin, troponin I), complement factors (C3, C4), C-reactive protein, transferrin, haptoglobin, alpha-1-antitrypsin, and other serum proteins. Custom contract antibody production services, with a minimum 9-month program length, allow customers to leverage the company's USDA-licensed facilities and immunization expertise for antigen-specific work not available in the standard catalog.

Nittobo America's business model is sales-led, relationship-driven, and entirely offline — no online ordering is available, and all orders are placed via phone, fax, mail, or email. Pricing is volume-based and quote-driven for bulk polyclonal antisera (typical quantities exceeding 100 mL), with net 30-day payment terms and standing-order arrangements for established customers. Revenue streams include bulk antisera sales under the IIC, MBC, and Capricorn brands, calibrator and control sales, fee-for-service custom antibody production, and immunoassay product development services. The company is wholly owned by Japanese parents Nitto Boseki Co., Ltd. and Nittobo Medical Co., Ltd., with no external venture capital or private equity involvement. Customer acquisition is pursued primarily through trade show presence at ADLM, MEDICA, and Immunology conferences, supplemented by a toll-free US/Canada sales line and direct sales contacts.

Name

Nittobo America

Legal name

Nittobo America Inc.

Website

https://nittobous.com

Company type

Private

Founded year

1986

Operating status

Operating

Short description

Nittobo America Inc. (NTB-A) is a primary manufacturer of bulk polyclonal antisera and calibrators for the in-vitro diagnostic industry, producing goat-derived antibodies in serum, IgG, and affinity-purified forms across three ISO-certified facilities in California, Iowa, and Maine.

Ownership category

akta.pro rank

Product category

In-Vitro Diagnostic Raw Materials

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Biologics & Immunotherapies (Non-vaccine) (HLAMAEAK)

Keywords

• Bulk polyclonal antisera
• Immunodiagnostic raw materials
• Polyclonal antibody production
• Turbidimetric immunoassay reagents
• Human serum calibrators

Headquarters

HQ city

Murrieta

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Bulk Polyclonal Antisera Sales: Primary revenue stream from manufacturing and selling bulk polyclonal antiserum products in various forms (serum, IgG fraction, affinity purified) to IVD diagnostic kit manufacturers. Products sold under IIC, MBC, and Capricorn brands. Pricing based on volume ordered, with typical bulk quantities exceeding 100mL.
2. Calibrators & Controls Sales: Sale of human serum calibrators and controls for immunoassay applications, including CRP, Lp(a), Apo A1/B, and other serum protein calibrators at various concentration levels.
3. Custom Contract Antibody Production: Fee-for-service custom polyclonal antibody production using customer-provided antigens. Services include husbandry, maintenance, immunization, bleeding, and administrative services. Minimum program length of 9 months with pricing based on individual contracted events.
4. Product Development Services: Immunoassay development services including polyclonal antibody production in goats, assay development for TIA, pilot manufacturing and ongoing product supply.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

Nittobo America is a primary manufacturer of bulk polyclonal antisera and complementing raw materials for in-vitro diagnostic (IVD) immunodiagnostic kit makers. It produces goat-derived polyclonal antiserum in multiple forms (serum, IgG fraction, gamma fraction, immunoaffinity purified) along with human serum calibrators and controls, monoclonal antibodies, antigens, and serum products. The company also offers custom contract polyclonal antibody production using customer-provided antigens in USDA-licensed facilities.

Product overview

Nittobo America Inc. (NTB-A) is a primary manufacturer of bulk polyclonal antiserum and calibrators for the immunodiagnostic assay industry. The company operates three distinct brands: IIC (established 1982, based in Murrieta, CA), MBC (founded 1987, based in Boone, IA), and Capricorn (established 1994, acquired 2019, based in Portland, ME). The product portfolio centers on goat polyclonal antisera to human proteins available in multiple forms (serum, gamma fraction, IgG fraction, affinity purified), complemented by human serum calibrators and controls, monoclonal products, and antigen products. The company also provides custom contract antibody production services using customer-provided antigens at USDA-licensed facilities. All three brands share core product categories including antisera to immunoglobulins (IgA, IgE, IgG, IgM), apolipoproteins (Apo AI, Apo B, Apo E, etc.), cardiac markers, C-reactive protein, complement factors, and general serum proteins, with calibrators for CRP, Lp(a), and Apolipoprotein testing.

Differentiator

Problem solved

Functional benefit

Brands

• IIC: Brand of immunodiagnostic products including bulk polyclonal antisera and calibrators, produced at the California facility.
• MBC
• Capricorn

Quantifiable outcome

• All antibody forms are monospecific by immunoelectrophoresis versus 1X pooled normal human plasma and 2X pooled human serum, high titered as determined by Becker SR1 and demonstrate high avidity in nephelometric, turbidimetric and enzyme immunoassay systems.

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Capricorn Products LLCcoreStrategic or Co-development Partner · 7 June 2019Acquired by Nittobo America in June 2019 (purchase agreement concluded June 7, 2019) and merged effective January 1, 2020. Capricorn Products LLC, Portland, ME was fully acquired to fulfill Nittobo America expansion plan for supply of bulk antiserum to the IVD industry. Now operates as Capricorn Brand under Nittobo America.

Scale indicators7 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Siemens Healthineers: Broad diagnostics platform including immunoassay analyzers (ADVIA Centaur, Atellica) that rely on bulk antibody reagents — comparable as a large-scale IVD buyer and competitor in the broader immunoassay value chain.
• Roche Diagnostics: Global diagnostics incumbent developing and manufacturing immunoassays that consume polyclonal/monoclonal raw materials at scale — comparable as an end-customer archetype and broad portfolio incumbent in clinical diagnostics.
• Bio-Rad Laboratories: Life science and clinical diagnostics manufacturer with antibody, reagent, and quality-control product lines — comparable as an incumbent supplier serving IVD kit developers and research labs with overlapping catalog.
• Abbott Diagnostics: Operates major immunoassay platforms (Architect, Alinity) sourcing large volumes of antibody raw materials — a key end-customer profile for Nittobo America's products and a broad incumbent in clinical diagnostics.

Direct peers

• Kamiya Biomedical Company: US-based affiliate within the Nittobo Group that co-exhibits at ADLM and MEDICA; supplies life-science antibodies and immunoassay reagents — directly comparable product portfolio with shared corporate parentage.
• Eurogentec (Kaneka): Custom antibody and peptide manufacturer serving IVD and research markets, including polyclonal antibody production services — comparable as a contract antibody production peer with similar custom services model.
• Fitzgerald Industries International: Manufacturer and supplier of polyclonal and monoclonal antibodies, antigens, and calibrators for the IVD and research industries — directly comparable as a niche antibody raw-material supplier serving diagnostic kit developers.
• Jackson ImmunoResearch: Primary manufacturer of affinity-purified polyclonal secondary antibodies used in immunoassays and research, with a comparable catalog breadth across host species and a similar B2B sales model targeting diagnostic and research laboratories.
• Meridian Life Science: Supplies biological raw materials including polyclonal antibodies, antigens, and diagnostic reagents to IVD manufacturers, comparable in target customers and product categories (immunoglobulins, infectious disease antigens).

Emerging players

• GenScript: Custom antibody services provider including polyclonal and monoclonal production for diagnostics and research, increasingly competitive in the custom contract antibody segment where Nittobo America competes.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nittobo America